Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Cartesian Therapeutics, Inc. (RNAC) had Receiveable Turnover of 44.62 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$38.91M |
|
$-77.42M |
|
-- |
|
$38.91M |
|
$82.81M |
|
$-43.90M |
|
$-33.24M |
|
$-77.14M |
|
$-77.14M |
|
$-77.42M |
|
$-77.42M |
|
$-77.42M |
|
$-77.42M |
|
$-43.90M |
|
$-42.75M |
|
17.28M |
|
17.36M |
|
$-4.48 |
|
$-4.49 |
|
| Balance Sheet Financials | |
$216.63M |
|
$9.91M |
|
$218.40M |
|
$435.02M |
|
$22.98M |
|
-- |
|
$418.85M |
|
$441.82M |
|
$-6.80M |
|
$-54.97M |
|
$-6.80M |
|
25.77M |
|
| Cash Flow Statement Financials | |
$-23.67M |
|
$-8.74M |
|
$168.43M |
|
$78.29M |
|
$214.28M |
|
$135.99M |
|
$6.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-112.81% |
|
-112.81% |
|
-109.85% |
|
-198.23% |
|
-198.97% |
|
$-32.42M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
|
Receiveable Turnover |
44.62 |
8.18 |
|
1138.26% |
|
140.86% |
|
-17.80% |
|
1138.25% |
|
$-0.26 |
|
$-1.87 |
|
$-1.36 |
|